Nephrol Dial Transplant
November 2000
Background: Serum/plasma albumin is an important predictor of future mortality/morbidity in haemodialysis (HD) patients and has been proposed as an important audit measure. Different methods of albumin assay give different results and the bias between methods may be greater in renal failure patients.
Methods: Albumin concentration in plasma was measured by three methods, two dye-binding methods (bromocresol green (BCG) and bromocresol purple (BCP)) and an immuno-turbidimetric (ITM) method, in 143 HD patients (group I) and 49 non-renal patients (group II).
Objectives: To investigate the association between multiple sclerosis, dental caries, amalgam fillings, body mercury and lead.
Design: Matched case-control study.
Setting: Leicestershire in the years 1989-1990.
Aims: To compare the prevalence of diabetes and abnormal glucose metabolism using conventional and suggested new WHO and new ADA criteria in a group of people with symptoms of diabetes.
Methods: We examined retrospectively the results of 154 consecutive OGTTs in such patients performed using capillary whole blood.
Results: With the 1985 WHO criteria.
J Ment Defic Res
December 1991
Patients with Down's syndrome are particularly vulnerable to the development of both hypothyroidism and Alzheimer's disease. Both hypothyroidism and Alzheimer's disease may be associated with elevated serum concentrations of thyroid stimulating hormone. In a group of institutionalized Down's syndrome patients with normal thyroid function, global scores of ability were higher than in a group of patients with elevated thyroid stimulating hormone levels in the presence of normal T3 and T4.
View Article and Find Full Text PDF